Skip to content
Screener

Utah Medical Products UTMD Q4 2025 Annual earnings

Reported January 29, 2026 · Before market open

Revenue$9.0M
EPS$0.80

Next report

Oct 22, 2026 (In 1 week)

Financials

Q4 2025

Income statement

See full
Revenue$9.0M-1.2%
Gross profit$5.3M-1.1%
Operating income$2.4M-16.7%
Net income$2.6M-11.6%
EPS (diluted)$0.80-7.0%

Balance sheet

See full
Cash & equivalents$85.8M+3.4%
Total debt$286.0K-49.3%
Total equity$119.3M+1.6%
Total assets$122.5M0.0%

Cash flow

See full
Operating cash flow$3.5M+18.4%
CapEx$109.0K+1,111%
Free cash flow$3.4M+15.0%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$179.28M-14.0%
Enterprise value$93.81M-25.6%
P/E15.9×+0.9×
P/S4.7×-0.4×

Profitability

See full
Gross margin57.1%-1.9pp
Operating margin29.6%-3.6pp
Net margin29.3%-4.6pp
FCF margin37.2%+1.5pp

Returns & leverage

See full
Return on equity9.5%-1.8pp
Debt / equity0×0.0×
Current ratio37.6×+12.0×

Segments

By product

See full
Gynecology/Electrosurgery/Urology$15.0M-6.6%
Blood Pressure Monitoring and Accessories$4.8M-5.8%
Neonatal$3.3M-4.3%
Obstetrics$1.7M-15.7%

By geography

See full
Global$9.6M-5.8%
Ous$3.9M-9.7%

FAQ

When did Utah Medical Products report Q4 2025 earnings?
Utah Medical Products (UTMD) reported Q4 2025 earnings on January 29, 2026 before market open.
What were Utah Medical Products's Q4 2025 revenue and EPS?
Utah Medical Products reported revenue of $9.0M and eps of $0.80 for Q4 2025.
How did Utah Medical Products's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 1.2% from $9.2M a year earlier and eps declined 6.7% from $0.86.
Where can I find Utah Medical Products's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001096906-26-000161) and the 10-K periodic report (0001096906-26-000395) directly on SEC EDGAR. The filing index links above go to sec.gov.